Nuveen’s ESSA Pharma EPIX Stock Holding History

Nuveen’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-29,216	Closed	-$181K	–	3323
2022 Q1	$181K	Buy	29,216 +2,397	+9%	+$21.1K	﹤0.01%	3204
2021 Q4	$381K	Buy	26,819 +4,177	+18%	+$46.5K	﹤0.01%	3131
2021 Q3	$181K	Buy	+22,642	New	+$360K	﹤0.01%	3285

Other funds holding EPIX

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Nuveen's EPIX Position: Q2 2022 in Review

Nuveen sold out of ESSA Pharma (EPIX) in Q2 2022, closing a stake of 29,216 shares — an estimated $181K sold.

Nuveen first reported a position in EPIX in Q3 2021 and held it in 3 quarters. The position peaked at $381K in Q4 2021. 59 funds tracked by Wall St. Rank hold EPIX as of Q2 2022.

Nuveen reported no remaining ESSA Pharma position as of Q2 2022 after selling out during the quarter.
Nuveen sold 29,216 ESSA Pharma shares in Q2 2022, an estimated $181K.
Nuveen first reported a position in ESSA Pharma in Q3 2021 and held it in 3 quarters.
Nuveen's ESSA Pharma position peaked at $381K in Q4 2021.
59 funds tracked by Wall St. Rank held ESSA Pharma as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.